Brian Seng, DO
Orthopaedic Surgery · Canton, GANPI 1477674877
Payments from drug & device makers
Across 71 payments — averaging $138.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Next Science LLC$4K
- Medical Device Business Services, Inc.$2K
- Medacta USA, Inc.$790
- Johnson & Johnson$716
- Zimmer Biomet$535
- Smith+Nephew$464
- plus $2K from 17 others
What the payments were for
- Consulting fees$3,50036%
- Travel & lodging$1,96720%
- Food & beverage$4,31744%
- Education$280%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Next Science LLC | 4 | $3,625 |
| Medical Device Business Services, Inc. | 7 | $1,545 |
| Medacta USA, Inc. | 8 | $790 |
| Johnson & Johnson(2 entities) | 9 | $716 |
| Zimmer Biomet | 8 | $535 |
| Smith+Nephew | 6 | $464 |
| Linkbio Corp | 2 | $456 |
| Innovation Technologies Inc | 2 | $280 |
| Stryker | 3 | $276 |
| Osteoremedies, LLC | 1 | $217 |
| Microport Orthopedics Inc | 1 | $186 |
| Heron Therapeutics, Inc. | 4 | $181 |
| Pacira Therapeutics, Inc. | 4 | $147 |
| Vertex | 3 | $97 |
| Medtronic | 1 | $64 |
| Sanara Medtech Inc. | 1 | $61 |
| Lima USA, Inc. | 1 | $56 |
| Convatec Inc. | 1 | $24 |
| Solventum Corporation | 1 | $24 |
| ERMI LLC | 1 | $24 |
| Avanos Medical | 1 | $18 |
| Acera Surgical, Inc. | 1 | $16 |
| Heraeus Medical, LLC. | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SurgX$3,500
- Xperience$3,500
- ATTUNE$1,517
- REAL INTELLIGENCE$434
- GMK SPHERE$290
- Journey II$284
- Irrisept$280
- GMK Sphere Revision System$260
- BIOWASH Surgical Irrigation$217
- OsteoBoost Select 5cc$217
- Remedy Spacer$217
- Remedy Spectrum GV Spacer$217
- BioBrush$217
- MPO Medial Pivot Knee$186
- Persona$150
- ZIPSEAL 16 SURGICAL SKIN CLOSURE KIT$140
- Journey II XR$138
- M-VIZION$124
- APONVIE$122
- Hips-None$110
How this compares
$9,812 in reported general payments places this provider in the 70th percentile of 654 orthopaedic surgery providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 374 | $1,134 |
| Methylprednisolone | 204 | $1,112 |
| Amoxicillin | 661 | $639 |
| Celecoxib | 21 | $468 |
| Diclofenac Sodium | 45 | $395 |
| Meloxicam | 147 | $383 |
| Tramadol Hcl | 146 | $364 |
| Pregabalin | 36 | $211 |
| Ibuprofen | 37 | $188 |
| Doxycycline Hyclate | 13 | $180 |
| Cefadroxil | 17 | $150 |
| Clindamycin Hcl | 158 | $145 |
| Methocarbamol | 24 | $94 |
| Ondansetron Hcl | 13 | $75 |
| Gabapentin | 16 | $75 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Canton
- Charles DecookCumming$48.3M
- Ormonde MahoneyAthens$10.8M
- Daxes BanitWarner Robins$5.7M
- John DorchakColumbus$3.8M
- Daniel SilcoxAtlanta$3.4M
- Dennis DevitoAtlanta$1.5M
- George GuildCumming$1.4M
- Jon MinterAlpharetta$1.4M
- Tuan BuiLawrenceville$1.1M
- William TallyAthens$870K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.